LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
5.33
-0.63 (-10.57%)
At close: Sep 8, 2026, 4:00 PM EDT
5.52
+0.19 (3.56%)
After-hours: Sep 8, 2026, 7:42 PM EDT
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $167.47 million as of September 8, 2026. Its market cap has decreased by -86.01% in one year.
Market Cap
167.47M
Enterprise Value
-51.96M
1-Year Change
-86.01%
Ranking
Category
Stock Price
$5.33
ChartMarket Cap Chart
Since March 22, 2024, LENZ Therapeutics's market cap has decreased from $413.64M to $167.47M, a decrease of -59.51%. That is a compound annual growth rate of -30.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 167.47M | -66.55% |
| Dec 31, 2025 | 500.64M | -36.94% |
| Dec 31, 2024 | 793.95M | 91.94% |
| Mar 22, 2024 | 413.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alpha Cognition | 207.33M |
| Precision BioSciences | 206.18M |
| Cue Biopharma | 199.34M |
| Innate Pharma | 191.23M |
| Satellos Bioscience | 190.92M |
| Canton Strategic Holdings | 181.67M |
| Korro Bio | 180.24M |
| Immunic | 178.88M |